Nonclinical Safety Pharmacology Study of the Herbal Product HAD-B1
HAD-B1 is a Korean herbal formula designed to treat solid tumors, and through cell experiments, it has proven to have an anticancer effect. The current study aims to test the safety of HAD-B1. This experiment is under the regulation of ICH. In order to find if HAD-B1 has any effect on the CNS, 0, 50...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Hindawi Limited
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/3aa9d6a638064f50a1c591ce8fa13361 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|